Raloxifene delivery systems for osteoporosis treatment

Kavas, Ayşegül
One of the osteoporosis drugs, Raloxifene (Ral) is systemically administrated in high dose at frequent intervals, causing high risk of side effects which influence all the body. As a solution to such issues, delivery systems providing controlled and sustained drug release at therapeutic level from a carrier have been studied recently. The aim of this study was to develop Ral- or Ral-poly(ethylene glycol) (PEG)-loaded poly(ε-caprolactone) (PCL) or PCL:poly(D,L-lactide-co-glycolide) (PLGA) microspheres and to evalute their potential usage. Mean diameters of the microspheres were around 1.5 μm. Ral-loaded PCL microspheres had maximum Ral encapsulation efficiency (%) because of high hydrophobic natures of Ral and PCL. Total amount of Ral released from Ral-PEG-loaded PCL:PLGA microspheres was significantly higher than from other microsphere groups. This finding can be ascribed to enhanced wettability of Ral and conversion of crystalline nature of Ral to amorphous form provided by Ral-PEG conjugation, resulting in increased water-solubility of Ral. Enhanced wettability of Ral increases degradation rates of PCL and PLGA by allowing more water penetration into the polymer matrix. Related with this outcome, Ral release from Ral-PEG-loaded PCL:PLGA microspheres resulted with significantly higher mineralization of female adipose-derived mesenchymal stem cells than other groups. In vitro cytotoxicity studies performed using adipose-derived stem cells demonstrated that all microspheres were non-toxic. It was demonstrated that Ral-PEG-loaded PCL:PLGA microsphere formulation provided increased Ral release rate and therefore enhanced mineralization of the stem cells compared to the other formulations in this study. This formulation holds promise for osteoporosis therapy as an effective controlled drug delivery system. For forthcoming studies, PEG conjugation to Ral presents the possibility of adjusting rate of Ral release from microspheres readily by changing PEG ratio in the conjugate.


Structural effects of simvastatin on liver rate tissue: Fourier transform infrared and Raman microspectroscopic studies
Garip, Sebnem; Bayari, Sevgi Haman; Severcan, Mete; Abbas, Sherif; Lednev, Igor K.; Severcan, Feride (2016-02-01)
Simvastatin is one of the most frequently prescribed statins because of its efficacy in the treatment of hypercholesterolemia, reducing cardiovascular risk and related mortality. Determination of its side effects on different tissues is mandatory to improve safe use of this drug. In the present study, the effects of simvastatin on molecular composition and structure of healthy rat livers were investigated by Fourier transform infrared and Raman imaging. Simvastatin-treated groups received 50 mg/kg/day simva...
Metformin – Cisplatin Combination Treatment Alters mRNA Expression of Hexokinase II Gene in LNCaP and PC3 Prostate Cancer Cell Lines
Durukan, Özlem; Evin, Emre; Arslan, Şevki; Adalı, Orhan (null; 2017-07-08)
Metformin is an antidiabetic drug with anticancer properties. Cisplatin is known as one of the most potent chemotherapeutics for treatment of various types of cancer. In order to overcome cisplatin resistance and toxicity, the drug can be combined with other chemotherapeutics that sensitize tumour cells to cisplatin. The ability of metformin to potentiate cisplatin-mediated killing of cancer cells in vitro, makes it a plausible candidate for combination with cisplatin-based therapy. The aim of this study is...
A Bayesian modeling and estimation framework for pharmacogenomics driven warfaring dosing
Öztaner, Serdar Murat; Taşkaya Temizel, Tuğba; Erdem, Remzi; Department of Medical Informatics (2014)
Recent studies have shown that the incorporation of genomics information into the drug dosing prediction formulations increases the accuracy of the drug dosing while decreasing the frequency of adverse drug effects. The current clinical approaches for drug dosing which are supported by the best pharmacogenomics algorithms explain only some percentage of the variance in dosing. The main objective of this study is to enhance the accuracy and efficacy of the warfarin dosing algorithms by using advanced methods...
Differential gene expression analysis related to extracellular matrix components in drug-resistant RPMI-8226 cell line
Mutlu, Pelin; Gündüz, Ufuk (Elsevier BV, 2012-4)
Drug resistance remains a major obstacle to the successful use of chemotherapeutic drugs for many types of cancers including multiple myeloma. It is becoming increasingly apparent that tumor microenvironment could provide a shelter to malignant plasma cells that allow their survival after initial drug exposure. This study demonstrates alterations in gene expression levels of several extracellular matrix (ECM) components in prednisone, vincristine and melphalan-resistant RPMI-8226 myeloma cells. Resistant RP...
Antinociceptive effects of hydromorphone, bupivacaine and biphalin released from PLGA polymer after intrathecal implantation in rats
Sendil, D; Bonney, IM; Carr, DB; Lipkowski, AW; Wise, DL; Hasırcı, Vasıf Nejat (2003-05-01)
Intraspinal drug delivery, based on the concept of controlling pain by delivering drug to a nociceptive target rich in opioid and other relevant receptors is increasingly used clinically. The therapeutic ratio for opioids or other centrally acting agents is potentially greater if they are administered intrathecally (i.t.) than outside the central nervous system (CNS). The present study was designed with the ultimate goal of formulating a controlled release system for intrathecal analgesia characterized by e...
Citation Formats
A. Kavas, “Raloxifene delivery systems for osteoporosis treatment,” Ph.D. - Doctoral Program, Middle East Technical University, 2014.